Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X
Analysis

Rapid Micro Biosystems raises $120m: improving contamination testing in pharma

Rapid Micro Biosystems has raised $120m in a funding round to support further expansion and uptake of its automated, rapid microbial detection technology for manufacturing, Growth Direct. What role has the Covid-19 played in highlighting the need for rapid and quality controlled microbial contamination testing?

Close
Close
Close

Go Top